Background No medium-term data are available on the random comparison between
everolimus-eluting bioresorbable vascular scaffolds and everolimus-eluting metallic stents …

Background Everolimus-eluting stent (EES) reduces the risk of restenosis in elective
percutaneous coronary intervention. However, the use of drug-eluting stent in patients with …

Background—The effect of β-blockers on infarct size when used in conjunction with primary
percutaneous coronary intervention is unknown. We hypothesize that metoprolol reduces …

Background: Treatment of patients with drug-eluting stent (DES) in-stent restenosis (ISR)
remains a major challenge. Objectives: This study evaluated the comparative efficacy of …

Background Even when low-density lipoprotein-cholesterol (LDL-C) levels are lower than
guideline thresholds, a residual risk of atherosclerosis remains. It is unknown whether …

Objectives: This study sought to compare the efficacy of drug-eluting balloons (DEB) with
that of everolimus-eluting stents (EES) in patients with bare-metal stents (BMS) in-stent …

Background Data for the safety and efficacy of new-generation drug-eluting stents at long-
term follow-up, and specifically in patients with ST-segment elevation myocardial infarction …

Objectives: The goal of this trial was to study the long-term effects of intravenous (IV)
metoprolol administration before reperfusion on left ventricular (LV) function and clinical …

Background—Pathological studies suggest that calcified coronary nodules are a rare cause
of thrombotic events. The frequency, distribution, predictors, and outcomes of calcified …

Objectives: This study sought to study the efficacy and safety of newer-generation drug-
eluting stents (DES) compared with bare-metal stents (BMS) in an appropriately powered …